How Lower Prices Could Broaden Access to Wegovy and OzempicBusiness PenFebruary 24, 2026 February 24, 2026 Novo Nordisk A/S (NYSE: NVO) has announced plans to cut the official list prices of some of its most widely used obesity and diabetes drugs...
